| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
43,125 |
31,969 |
$2.85M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,954 |
15,316 |
$2.44M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
16,412 |
4,568 |
$1.29M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
7,401 |
1,491 |
$716K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,556 |
6,165 |
$689K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
7,940 |
1,785 |
$682K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,764 |
1,629 |
$635K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,486 |
4,265 |
$631K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,295 |
4,795 |
$627K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,352 |
1,876 |
$572K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,184 |
2,656 |
$468K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,506 |
1,433 |
$371K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,615 |
1,496 |
$356K |
| G0378 |
Hospital observation service, per hour |
1,830 |
1,491 |
$302K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,242 |
1,152 |
$173K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
822 |
632 |
$168K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,168 |
1,019 |
$163K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
477 |
445 |
$162K |
| 20610 |
|
731 |
683 |
$133K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,362 |
2,073 |
$121K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,567 |
3,272 |
$114K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,230 |
852 |
$96K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,147 |
5,343 |
$89K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,626 |
914 |
$87K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,845 |
3,874 |
$86K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
286 |
264 |
$85K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
136 |
122 |
$81K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,402 |
4,821 |
$80K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
512 |
498 |
$72K |
| 80053 |
Comprehensive metabolic panel |
17,725 |
14,418 |
$71K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
230 |
210 |
$70K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
522 |
489 |
$68K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,402 |
4,579 |
$64K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,220 |
4,197 |
$64K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
137 |
128 |
$59K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
229 |
212 |
$56K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
486 |
466 |
$56K |
| J3490 |
Unclassified drugs |
16,500 |
8,139 |
$56K |
| 71046 |
Radiologic examination, chest; 2 views |
1,431 |
1,356 |
$54K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,604 |
15,807 |
$52K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
528 |
280 |
$52K |
| 97113 |
|
497 |
160 |
$51K |
| 97162 |
|
1,128 |
1,092 |
$48K |
| 97166 |
|
330 |
312 |
$40K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
524 |
506 |
$39K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
84 |
81 |
$39K |
| 71045 |
Radiologic examination, chest; single view |
2,973 |
2,699 |
$38K |
| 93017 |
|
163 |
146 |
$36K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,307 |
2,744 |
$35K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
318 |
196 |
$33K |
| 20553 |
|
140 |
132 |
$32K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
176 |
165 |
$32K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
865 |
862 |
$31K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,353 |
1,251 |
$30K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
12 |
12 |
$28K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,970 |
2,360 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,438 |
2,289 |
$23K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,859 |
3,505 |
$22K |
| 64615 |
|
75 |
69 |
$21K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
7,087 |
3,584 |
$20K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
976 |
791 |
$19K |
| 95886 |
|
96 |
83 |
$18K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
51 |
49 |
$17K |
| 97161 |
|
873 |
818 |
$17K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
723 |
721 |
$16K |
| 90670 |
|
219 |
219 |
$16K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
20 |
17 |
$15K |
| 94729 |
|
630 |
582 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
9,520 |
7,607 |
$14K |
| A9270 |
Non-covered item or service |
1,961 |
1,168 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
2,058 |
1,908 |
$12K |
| 94010 |
|
273 |
248 |
$12K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
281 |
273 |
$11K |
| 97014 |
|
253 |
89 |
$11K |
| 97760 |
|
190 |
176 |
$11K |
| 94060 |
|
288 |
269 |
$11K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
52 |
51 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
82 |
77 |
$10K |
| 83880 |
|
1,022 |
907 |
$10K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,760 |
2,076 |
$10K |
| 87070 |
|
1,418 |
1,321 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,156 |
4,167 |
$9K |
| 86850 |
|
1,098 |
1,022 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
275 |
262 |
$9K |
| 86900 |
|
1,204 |
1,110 |
$9K |
| 84484 |
|
2,996 |
2,082 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,978 |
1,571 |
$8K |
| 87186 |
|
1,649 |
1,529 |
$8K |
| 81001 |
|
5,852 |
5,265 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
288 |
276 |
$8K |
| 73610 |
|
429 |
380 |
$8K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
841 |
755 |
$8K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
9,079 |
3,944 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
122 |
120 |
$8K |
| 93971 |
|
81 |
75 |
$8K |
| 80061 |
Lipid panel |
1,450 |
1,386 |
$8K |
| 62323 |
|
13 |
12 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,055 |
2,597 |
$7K |
| 83735 |
|
3,455 |
2,468 |
$7K |
| 83605 |
|
2,499 |
2,145 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,244 |
2,678 |
$7K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
298 |
259 |
$6K |
| 84703 |
|
2,218 |
2,056 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,578 |
3,043 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
183 |
174 |
$5K |
| 0099U |
|
46 |
44 |
$5K |
| 73030 |
|
453 |
408 |
$5K |
| 90651 |
|
29 |
28 |
$5K |
| 83690 |
|
2,325 |
2,096 |
$5K |
| Q3014 |
Telehealth originating site facility fee |
387 |
353 |
$5K |
| 59025 |
Fetal non-stress test |
51 |
38 |
$5K |
| 87088 |
|
1,180 |
1,096 |
$4K |
| 90681 |
|
111 |
110 |
$4K |
| 82962 |
|
3,843 |
1,800 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
285 |
274 |
$4K |
| 85027 |
|
1,141 |
903 |
$4K |
| 97597 |
|
36 |
25 |
$4K |
| 84439 |
|
439 |
417 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
664 |
623 |
$4K |
| 73630 |
|
189 |
175 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,926 |
2,830 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,271 |
887 |
$4K |
| 81003 |
|
994 |
921 |
$4K |
| 97803 |
|
283 |
281 |
$4K |
| 82803 |
|
852 |
749 |
$3K |
| 90686 |
|
528 |
523 |
$3K |
| 86140 |
|
723 |
666 |
$3K |
| 90723 |
|
158 |
158 |
$3K |
| 97035 |
|
23 |
12 |
$3K |
| 82553 |
|
839 |
702 |
$3K |
| 73130 |
|
261 |
227 |
$3K |
| 90647 |
|
141 |
141 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
119 |
83 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
795 |
623 |
$3K |
| 94726 |
|
130 |
121 |
$3K |
| 90716 |
|
32 |
32 |
$3K |
| 82550 |
|
1,266 |
1,055 |
$3K |
| 71250 |
|
27 |
26 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
43 |
39 |
$3K |
| 90707 |
|
39 |
39 |
$2K |
| 76536 |
|
12 |
12 |
$2K |
| 72141 |
|
15 |
15 |
$2K |
| 95885 |
|
12 |
12 |
$2K |
| 74018 |
|
70 |
64 |
$2K |
| 20552 |
|
14 |
12 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
25 |
25 |
$2K |
| 83655 |
|
130 |
128 |
$2K |
| 96367 |
|
37 |
27 |
$2K |
| 94664 |
|
75 |
68 |
$2K |
| 73221 |
|
13 |
12 |
$2K |
| 87205 |
|
872 |
803 |
$2K |
| 87077 |
|
477 |
438 |
$2K |
| 96376 |
|
147 |
123 |
$2K |
| 93299 |
|
119 |
111 |
$2K |
| 90461 |
|
86 |
86 |
$2K |
| 85610 |
|
1,557 |
1,254 |
$2K |
| 73560 |
|
119 |
104 |
$2K |
| 97802 |
|
55 |
52 |
$2K |
| 90696 |
|
41 |
41 |
$2K |
| 0097U |
|
12 |
12 |
$2K |
| 82607 |
|
206 |
195 |
$2K |
| 82728 |
|
372 |
353 |
$2K |
| 86901 |
|
1,164 |
1,072 |
$2K |
| 87040 |
|
662 |
383 |
$2K |
| 73562 |
|
295 |
281 |
$2K |
| 87081 |
|
208 |
204 |
$2K |
| 36000 |
|
43 |
41 |
$1K |
| 36591 |
|
482 |
289 |
$1K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
14 |
12 |
$1K |
| 85379 |
|
716 |
670 |
$1K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
14 |
13 |
$1K |
| 72110 |
|
26 |
26 |
$1K |
| 29125 |
|
56 |
53 |
$1K |
| 73110 |
|
110 |
100 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
784 |
636 |
$1K |
| 70486 |
|
12 |
12 |
$1K |
| 94644 |
|
15 |
13 |
$973.80 |
| 51798 |
|
84 |
78 |
$932.57 |
| 83540 |
|
330 |
313 |
$895.95 |
| 73502 |
|
46 |
43 |
$861.18 |
| 80329 |
|
198 |
118 |
$831.60 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
666 |
535 |
$816.17 |
| 83550 |
|
275 |
259 |
$770.09 |
| 84145 |
|
582 |
468 |
$761.99 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
267 |
216 |
$757.92 |
| 73100 |
|
32 |
26 |
$749.36 |
| 80050 |
General health panel |
18 |
18 |
$741.54 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
46 |
27 |
$710.79 |
| 85652 |
|
443 |
402 |
$660.13 |
| 90633 |
|
41 |
41 |
$641.20 |
| 94761 |
|
1,145 |
865 |
$589.37 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
18 |
17 |
$536.04 |
| 83525 |
|
38 |
36 |
$492.51 |
| 12001 |
|
12 |
12 |
$435.49 |
| 85730 |
|
104 |
91 |
$430.64 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
15 |
14 |
$414.30 |
| 90734 |
|
16 |
15 |
$388.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
49 |
49 |
$379.57 |
| 97116 |
|
27 |
13 |
$351.83 |
| 73564 |
|
16 |
16 |
$322.18 |
| 85018 |
|
87 |
86 |
$254.91 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
15 |
14 |
$231.77 |
| 84702 |
|
44 |
36 |
$200.38 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
301 |
249 |
$188.22 |
| 99152 |
|
87 |
82 |
$176.99 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
386 |
364 |
$149.90 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
25 |
25 |
$143.23 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
35 |
26 |
$126.50 |
| 82540 |
|
28 |
26 |
$110.55 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
15 |
12 |
$107.12 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
736 |
585 |
$106.53 |
| G0008 |
Administration of influenza virus vaccine |
96 |
88 |
$103.65 |
| 94760 |
|
284 |
247 |
$93.36 |
| 99156 |
|
81 |
74 |
$76.44 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
25 |
24 |
$75.90 |
| 80069 |
|
15 |
12 |
$60.60 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
2,147 |
1,867 |
$47.64 |
| 99153 |
Mod sedat endo service >5yrs |
16 |
15 |
$38.99 |
| 99157 |
|
61 |
53 |
$38.22 |
| 86200 |
|
15 |
14 |
$32.84 |
| 84100 |
|
15 |
12 |
$25.82 |
| 82565 |
|
16 |
15 |
$25.73 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
327 |
233 |
$23.18 |
| J2060 |
Injection, lorazepam, 2 mg |
279 |
230 |
$18.15 |
| 80320 |
|
43 |
39 |
$16.27 |
| 82784 |
|
12 |
12 |
$11.79 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,771 |
2,439 |
$11.68 |
| 36592 |
|
74 |
55 |
$6.58 |
| 86803 |
|
12 |
12 |
$1.51 |
| 83615 |
|
27 |
25 |
$0.56 |
| C1769 |
Guide wire |
134 |
122 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
134 |
121 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
137 |
81 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
91 |
83 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
14 |
13 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
26 |
14 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
17 |
17 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
16 |
14 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
15 |
13 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
378 |
343 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
61 |
38 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
135 |
128 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
281 |
251 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
119 |
103 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
120 |
103 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
68 |
56 |
$0.00 |
| 80347 |
|
12 |
12 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
215 |
94 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
63 |
53 |
$0.00 |
| 80326 |
|
12 |
12 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
33 |
28 |
$0.00 |
| 80364 |
|
12 |
12 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
39 |
39 |
$0.00 |